Coronavirus: WHO tells doctors don’t use Gilead’s remdesivir, splitting with FDA

A WHO panel advised doctors against using Gilead Sciences’ antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19.

The group said there is currently “no evidence” that it improves survival rates or the need for ventilation.

The recommendation was published in the British medical trade journal The BMJ on Friday in the EU.

CNBC Coronavirus: WHO tells doctors don’t use Gilead’s remdesivir, splitting with FDA